348 related articles for article (PubMed ID: 9730558)
1. Plasma homocysteine, vitamin B6, vitamin B12 and folic acid in end-stage renal disease during low-dose supplementation with folic acid.
Hong SY; Yang DH; Chang SK
Am J Nephrol; 1998; 18(5):367-72. PubMed ID: 9730558
[TBL] [Abstract][Full Text] [Related]
2. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
3. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
4. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
Dierkes J; Domröse U; Bosselmann KP; Neumann KH; Luley C
J Ren Nutr; 2001 Apr; 11(2):67-72. PubMed ID: 11295026
[TBL] [Abstract][Full Text] [Related]
6. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.
Moustapha A; Gupta A; Robinson K; Arheart K; Jacobsen DW; Schreiber MJ; Dennis VW
Kidney Int; 1999 Apr; 55(4):1470-5. PubMed ID: 10201012
[TBL] [Abstract][Full Text] [Related]
8. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
[TBL] [Abstract][Full Text] [Related]
9. Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients.
Jungers P; Joly D; Massy Z; Chauveau P; Nguyen AT; Aupetit J; Chadefaux B
Nephrol Dial Transplant; 1999 Dec; 14(12):2903-6. PubMed ID: 10570095
[TBL] [Abstract][Full Text] [Related]
10. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
[TBL] [Abstract][Full Text] [Related]
11. Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients.
Polkinghorne KR; Zoungas S; Branley P; Villanueva E; McNeil JJ; Atkins RC; McGrath BP; Kerr PG
Intern Med J; 2003 Nov; 33(11):489-94. PubMed ID: 14656250
[TBL] [Abstract][Full Text] [Related]
12. A tale of two homocysteines--and two hemodialysis units.
Hoffer LJ; Bank I; Hongsprabhas P; Shrier I; Saboohi F; Davidman M; Bercovitch DD; Barré PE
Metabolism; 2000 Feb; 49(2):215-9. PubMed ID: 10690947
[TBL] [Abstract][Full Text] [Related]
13. Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients.
Tungkasereerak P; Ong-ajyooth L; Chaiyasoot W; Ong-ajyooth S; Leowattana W; Vasuvattakul S; Vareesangthip K; Shayakul C; Chanchairujira T; Sritippayawan S
J Med Assoc Thai; 2006 Aug; 89(8):1187-93. PubMed ID: 17048428
[TBL] [Abstract][Full Text] [Related]
14. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.
Robinson K; Gupta A; Dennis V; Arheart K; Chaudhary D; Green R; Vigo P; Mayer EL; Selhub J; Kutner M; Jacobsen DW
Circulation; 1996 Dec; 94(11):2743-8. PubMed ID: 8941098
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation.
Cetin O; Bekpinar S; Unlucerci Y; Turkmen A; Bayram C; Ulutin T
Clin Nephrol; 2006 Feb; 65(2):97-102. PubMed ID: 16509458
[TBL] [Abstract][Full Text] [Related]
18. The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis.
Ziakka S; Rammos G; Kountouris S; Doulgerakis C; Karakasis P; Kourvelou C; Papagalanis N
Int Urol Nephrol; 2001; 33(3):559-62. PubMed ID: 12230295
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
